2020
Altered FDG Biodistribution in Subcutaneous White Fat on PET/CT Following l-Asparaginase Chemotherapy.
Young CR, Kulon ME, Boustani AM, Pucar D. Altered FDG Biodistribution in Subcutaneous White Fat on PET/CT Following l-Asparaginase Chemotherapy. Clinical Nuclear Medicine 2020, 46: e179-e180. PMID: 33086270, DOI: 10.1097/rlu.0000000000003340.Peer-Reviewed Original ResearchConceptsPET/CTAltered biodistributionMediastinal T-cell lymphoblastic lymphomaPosttreatment FDG PET/CTFDG PET/CTT-cell lymphoblastic lymphomaSubcutaneous white adipose tissueWhite adipose tissueTreatment response assessmentSubcutaneous white fatAsparaginase chemotherapyLymphoblastic lymphomaAsparaginase resistanceFDG biodistributionResponse assessmentWhite fatGlucose metabolismAdipose tissueTreatment cyclesLeukemic cellsVisceral activityCTBiodistributionChemotherapyDiffuse activityDiagnostic approach to primary retroperitoneal pathologies: what the radiologist needs to know
Czeyda-Pommersheim F, Menias C, Boustani A, Revzin M. Diagnostic approach to primary retroperitoneal pathologies: what the radiologist needs to know. Abdominal Radiology 2020, 46: 1062-1081. PMID: 32944824, DOI: 10.1007/s00261-020-02752-8.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2018
Superior Pituitary Border Analysis in Immunotherapy-Induced Hypophysitis
Pucar D, Boustani AM, Bronen RA, Saperstein L. Superior Pituitary Border Analysis in Immunotherapy-Induced Hypophysitis. Clinical Nuclear Medicine 2018, 43: 284-286. PMID: 29401149, DOI: 10.1097/rlu.0000000000001981.Peer-Reviewed Educational MaterialsConceptsSinus diseasePituitary swellingSevere headacheVisual disturbancesLaboratory findingsMetastatic melanomaPituitary abnormalitiesRetrospective analysisContrast CTNoncontrast CTPituitary hormonesHypophysitisHeadacheDiseaseDiagnosisCTLow levelsNivolumabHypermetabolismImmunotherapyPETMelanomaAbnormalitiesFindingsHormoneMolecular imaging of prostate cancer
Boustani AM, Pucar D, Saperstein L. Molecular imaging of prostate cancer. British Journal Of Radiology 2018, 91: 20170736. PMID: 29243485, PMCID: PMC5966010, DOI: 10.1259/bjr.20170736.Peer-Reviewed Original ResearchConceptsProstate cancerNational Comprehensive Cancer Network guidelinesMetastatic diseaseMolecular imagingCommon malignancyNetwork guidelinesEffective treatmentMolecular imaging techniquesCancerMetabolic intermediaryTreatmentImaging techniquesRelevant radiotracersImagingTimely detectionAccurate imagingChemotherapySurgeryRecurrenceMalignancyDiseaseReceptors